Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.63

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.15

Views

Views
July 20257
August 20250
September 20257
October 20250
November 20250
December 20250
January 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil3
Germany1
Singapore1
 

Top cities views

Views
Dallas6
Bronxville1
Cataguases1
Chicago1
Hamburg1
São Paulo1
Taquara1